US OptionsDetailed Quotes

VIR241115P5000

Watchlist

0.04
0.000.00%

15min DelayClose Nov 1 16:00 ET

0.04High0.04Low

Vir Biotechnology Stock Discussion

QMengColdJoke

Sep 12 10:43

Very displeased cfo pick

$Vir Biotechnology (VIR.US)$ now you wany to sell company. But f you we have 10 dollar per share in equity and that is in cash. Cutting edge science, at least worth 10 dollar. You want to sell right now for how much? 10 dollar? I would sue you if you sell company below 20 dollar.
Firstly of first you need to pump to 20

Trytosaveabit

Sep 9 15:10

Update

$Vir Biotechnology (VIR.US)$ $Sanofi (SNY.US)$ Reuters· 4 mins ago
Vir Biotechnology Announces Closing of Exclusive Worldwide License Agreement With Sanofi for Multiple Potential Best-in-Class Clinical-Stage T-Cell Engagers

QMengColdJoke

Aug 1 17:05

So no more HIV no more covid?

$Vir Biotechnology (VIR.US)$ Good news is my position in GILD is safe. Sick but hell if you boost price to 20, I’ll love to leave. Oncology is crowded path, bad idea.
your own platform is most valuable and made 2 Billion for the company. You just let people go…

Trytosaveabit

Jun 26 07:17

News

$Vir Biotechnology (VIR.US)$ Vir Biotechnology Receives FDA Ind Clearance and Fast Track Designation for Tobevibart and Elebsiran for the Treatment of Chronic Hepatitis Delta Infection

Trytosaveabit

Jun 5 04:45

Update

$Vir Biotechnology (VIR.US)$ Vir Biotechnology Announced New Preliminary Data From Phase 2 SOLSTICE Hepatitis Delta Trial, Showing Tobevibart Alone Or Combined With Elebsiran Was Generally Well Tolerated And Patients Achieved High Virologic Response And ALT Normalization

QMengColdJoke

May 22 13:36

need to break 12 to confirm a bottom!

$Vir Biotechnology (VIR.US)$ still too cheap!

Meltyy

May 22 02:52

Biotech Stock Catalyst Watchlist 👀

🎯 Ph 2 readouts in Q2 2024...
$Iovance Biotherapeutics (IOVA.US)$ Phase 2
$Supernus Pharmaceuticals (SUPN.US)$ Phase 2a
$BRANDES INTERNATIONAL ETF (BINV.US)$ Phase 2a
$MorphoSys (MOR.US)$ Phase 2
$Nuvation Bio (NUVB.US)$ Phase 2
$ALX Oncology (ALXO.US)$ Phase 2
$BioXcel Therapeutics (BTAI.US)$ Phase 2
$Purple Biotech (PPBT.US)$ Phase 2
$Arcus Biosciences (RCUS.US)$ Phase 2
$Medicenna Therapeutics (MDNAF.US)$ Phase 2b
$Affimed NV (AFMD.US)$ Phase 2
$Barinthus Biotherapeutics (BRNS.US)$ Phase 2b...

QMengColdJoke

Apr 18 11:33

I think CFO is actually fired.

$Vir Biotechnology (VIR.US)$ They need better cost control and accounting practice to boost share price to a reasonable level (say 20). Section is bad because of Biden, but literally science is priced at 0 for VIR. Active investor should interfere. I’ll vote all Against in proxy, as I am not happy at all.

QMengColdJoke

Feb 22 17:26

good earnings but i don’t like

$Vir Biotechnology (VIR.US)$ small scale experiments are good.
no idea why they issue cost guidance (huge) without revenue guidance. Stupid.
I don’t like new management goes back to clinical stage biotech. They hire too many people and relocate position to high salary area. AI expert in San Francisco, come on… If not sotrovimab and help of GSK made huge money, this company would have doomed.(if not stopped by Biden, would have been 40 dollar per share). I’ll start...

Movers and Shakers

Jan 29 07:19

Columns Today's Morning Movers and Top Ratings: MSFT, ZI, AAL, HSY and More

Morning Movers
Gapping up
$ZoomInfo (ZI.US)$ The software stock popped 5.5% after Bank of America analyst Koji Ikeda upgraded it to buy from neutral. “We believe it is a classic self-help story that is set to outperform,” the analyst wrote, underscoring the company’s revenue growth reacceleration and new AI products as potential catalysts.
$Boeing (BA.US)$ stock rose 0.9% after Ryanair, Europe's largest airline by passenger number...

No comment yet